TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has announced a change of its company name to Adheris Health Limited, alongside a new ASX code, AHE, effective from December 1, 2025. This rebranding, approved at the 2025 Annual General Meeting, reflects the company’s commitment to enhancing its market presence and operational focus in pharmacy-driven patient engagement solutions.
The most recent analyst rating on (AU:MDR) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
Adheris Health (ASX: AHE), formerly known as MedAdvisor Solutions, is a leader in pharmacy-driven patient engagement solutions. The company provides personalized patient experiences to simplify the medication journey, leveraging THRiV, a cloud-based, AI-enabled platform. Adheris Health collaborates with over 34,000 pharmacies across the US, reaching over two-thirds of the population.
Average Trading Volume: 1,583,466
Technical Sentiment Signal: Sell
Current Market Cap: A$12.73M
Find detailed analytics on MDR stock on TipRanks’ Stock Analysis page.